Parnassus Investments
RVMD icon

Parnassus Investments’s Revolution Medicines RVMD Stock Holding History

Parnassus Investments’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.7M Buy
+99,988
New +$14.6M 0.05% 109

Other funds holding RVMD

CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
FAF
Fjarde Ap-fonden Stockholm, Sweden $20.9B AUM 36.93% 1-Year Est. Return
APM
a16z Perennial Management Menlo Park, California $1.24B AUM 7.36% 1-Year Est. Return
RAM
Resona Asset Management Koto-Ku,tokyo, Japan $21.3B AUM 36.92% 1-Year Est. Return

Parnassus Investments's RVMD Position: Q2 2026 in Review

Parnassus Investments opened a new position in Revolution Medicines (RVMD) in Q2 2026: 99,988 shares worth $18.7M. The stake represents 0.05% of the portfolio and ranks #109 among its holdings.

166 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Parnassus Investments held 99,988 shares of Revolution Medicines worth $18.7M as of Q2 2026.
  • Revolution Medicines was a new Parnassus Investments position in Q2 2026.
  • Revolution Medicines made up 0.05% of Parnassus Investments's portfolio in Q2 2026, its #109 holding.
  • 166 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Parnassus Investments's 13F filing for Q2 2026, filed 29 Jul 2026.